Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2024) 212 (10): 1521.

BRIEF REVIEWS

J Immunol (2024) 212 (10): 1523–1529.

ALLERGY AND OTHER HYPERSENSITIVITIES

J Immunol (2024) 212 (10): 1531–1539.

  • TER119 ameliorates murine ITP while triggering adverse inflammation.

  • PAF-R antagonist mitigates TER119-induced temperature change and cytokine release.

  • Phagocytes and functional TER119 Fc are required for TER119-induced inflammation.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2024) 212 (10): 1540–1552.

  • Coinhibitory receptors are associated with B cell dysregulation.

  • Metabolomic alteration and elevated IL-6 contribute to B cell dysfunction.

  • The spike protein promotes B cell apoptosis in COVID-19 patients.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2024) 212 (10): 1553–1563.

  • FcRg- Adaptive NK cells are expanded very early in acute HIV infection.

  • NK cell dysfunction persists despite early ART initiation.

  • Adaptive NK cells are associated with HIV DNA levels.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2024) 212 (10): 1564–1578.

  • NK cells progress along a spectrum of differentiation in PWH on long-term ART.

  • Conventional but not FcRγ NK cells downregulate KLRG1 upon IL-18+IL-12 exposure.

  • PWH display atypical NK cell subsets, representing intermediate stages of NK-poiesis.

SYSTEMS IMMUNOLOGY

J Immunol (2024) 212 (10): 1579–1588.

  • Using paired BCR sequences improves accuracy and reproducibility of lineage trees.

  • Multipartition models outperform other methods when some L chains are missing.

  • These methods are available in the R package Dowser.

TUMOR IMMUNOLOGY

J Immunol (2024) 212 (10): 1589–1601.

  • A tumor-specific complement-activating Ab, GT103, enhances antitumor immunity.

  • GT103 inhibits immunosuppression and promotes effector T cell activation in the TME.

  • A human autoantibody targeting the GT103 epitope enhances antitumor immunity in situ.

CORRECTIONS

J Immunol (2024) 212 (10): 1602.
J Immunol (2024) 212 (10): 1603.

EXPRESSIONS OF CONCERN

J Immunol (2024) 212 (10): 1604.
Close Modal

or Create an Account

Close Modal
Close Modal